Neuroprotective effects of novel EAAT2 allosteric modulators in excitotoxic and ischemic injury models
Brain Research · 2026-12 · 1893 · 150560
DOI: 10.1016/j.brainres.2026.150560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2026-12. Verfasst von Katelyn L Reeb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia 19102, PA, USA. Hauptthemen laut MEDLINE: Neuroprotective Agents, Excitatory Amino Acid Transporter 2, Brain Ischemia. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Excitatory amino acid transporters (EAATs) regulate extracellular glutamate levels in the central nervous system, and impairment of their function contributes to excitotoxic neuronal injury in ischemic stroke and other neurological disorders. We investigated the neuroprotective properties of novel EAAT2 allosteric modulators in primary neuron-glia cultures subjected to glutamate-induced excitotoxicity or oxygen-glucose deprivation (OGD), an in vitro model of ischemic injury. The EAAT2-selective positive allosteric modulator (PAM) NA-014 increased neuronal survival in both injury paradigms and remained effective when administered several hours after insult. In contrast, the EAAT2-selective negative allosteric modulator (NAM) NA-010 reduced neuronal survival, whereas an inactive analog had no effect. Neuroprotection by NA-014 was abolished by the EAAT2 inhibitor WAY-213613, supporting an EAAT2-dependent mechanism. Calcium imaging demonstrated that co-application of NA-014 attenuated glutamate-evoked intracellular Ca2+ responses, while morphological analyses indicated partial preservation of neuronal structure. In contrast to the EAAT2-selective PAM, the non-selective EAAT1/2/3 PAM did not confer neuroprotection, suggesting that transporter selectivity or differences in the mechanisms of modulation may influence neuroprotective efficacy. Together, these findings identify NA-014 as a promising neuroprotective candidate and support selective EAAT2 modulation as a potential therapeutic strategy for excitotoxic and ischemic brain injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia 19102, PA, USA.
- Medicinal Chemistry, Molecular and Cellular Oncogenesis (MCO) Program, The Wistar Cancer Center Molecular Screening, The Wistar Institute, Philadelphia 19104, PA, USA.
- Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia 19102, PA, USA. Electronic address: acm83@drexel.edu.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- PhRMA Foundation
Zitieren
APA
Reeb, K. L., Gill, S. K., Hall, J. L., Reddy Poli, A. N., Salvino, J. M., & Fontana, A. C. K. (2026). Neuroprotective effects of novel EAAT2 allosteric modulators in excitotoxic and ischemic injury models. Brain Research, 1893, 150560. https://doi.org/10.1016/j.brainres.2026.150560
Vancouver
Reeb KL, Gill SK, Hall JL, Reddy Poli AN, Salvino JM, Fontana ACK. Neuroprotective effects of novel EAAT2 allosteric modulators in excitotoxic and ischemic injury models. Brain Research. 2026;1893:150560. doi:10.1016/j.brainres.2026.150560
BibTeX
@article{Reeb2026,
author = {Reeb, Katelyn L and Gill, Simran K and Hall, Jennifer L and Reddy Poli, Adi Narayana and Salvino, Joseph M and Fontana, Andréia C K},
title = {Neuroprotective effects of novel EAAT2 allosteric modulators in excitotoxic and ischemic injury models},
journal = {Brain Research},
year = {2026},
volume = {1893},
pages = {150560},
doi = {10.1016/j.brainres.2026.150560}
}
EUVIMED